BioGenex Life Sciences Private Limited

BioGenex is an American diagnostic company established in 1981 in San Ramon, CA with a mission to provide affordable solutions for life science research and personalized medicine.

BioGenex designs, develops, and commercializes automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The company offers a range of slide-based tissue and cell staining products to support assay development for clinical diagnosis and translational research. The product range includes a wide variety of primary antibodies, high sensitive detection kits, automated systems, probes, antigen retrieval systems, and histology stains. BioGenex prides itself on delivering innovative products, years ahead of the competition in the field of immunohistochemistry (IHC) and in situ hybridization (ISH). BioGenex holds a strong intellectual portfolio with the several US and foreign-issued patents.

BioGenex offers a broad range of slide-based tissue staining products to support assay development in translational research and clinical diagnosis of cancers for molecular pathology labs. Some of these applications include:

Immunohistochemistry (IHC) – total automation and walkway solution including – instruments, primary antibodies, detection system and reagents for the localization of antigen within a cell or a tissue preparation of various types.

in situ hybridization (ISH) - for precise detection and localization of a specific nucleic acid sequence within a histologic section. Our ISH solution covers automated instruments, systems, along with probes, detection systems, ancillaries and nucleic acid retrieval system.

Fluorescent in situ hybridization (FISH) - to check for genetic abnormalities associated with prenatal diagnosis, cancer, birth defects, and mental retardation. Our BioGenex FISH offerings includes industry-first total FISH automation systems along with probes and detection kits.

microRNA ISH – We caters specialize Biomarker miRNA Probe panels for characterization of CUP and poorly differentiated tumors with an industry first extensive list of 235 probes. Our miRNA probes integrate seamlessly with our automation solutions.

BioGenex also provide solutions for multiplexing, special staining, in situ PCR and specialized antigen retrieval systems.

More info : https://www.biogenex.com